Bristol Myers wins dismissal of lawsuit over Celgene drugs By Reuters


© Reuters. FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder

NEW YORK (Reuters) – A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers (NYSE:) Squibb Co of defrauding investors who stood to receive $6.4 billion had it won federal approval by specified deadlines for drugs developed by the former Celgene Corp (NASDAQ:).

#Bristol #Myers #wins #dismissal #lawsuit #Celgene #drugs #Reuters

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *